Recruiting
Blood Pressure Control With Thiazide Diuretics in Peritoneal Dialysis Patients
To evaluate the blood pressure lowering effects of thiazide diuretics in patients on peritoneal dialysis
ClinicalTrials.gov IDNCT07271420
PhasePHASE4
Enrollment40
SponsorChinese University of Hong Kong
Age18 Years
SexALL
Conditions studied
Hypertension, Peritoneal Dialysis, End Stage Kidney Disease (ESRD)
About this study
To evaluate the blood pressure lowering effects of thiazide diuretics in patients on peritoneal dialysis
Interventions
- Drug: Hydrochlorothiazide 25mg once per day — Thiazides diuretics
Primary outcomes
- Change in systolic and diastolic blood pressure (90 days)
Eligibility information
Inclusion Criteria:
* Patients on chronic peritoneal dialysis, with uncontrolled hypertension (SBP \>140 mmHg and/or DBP \>90 mmHg)
Exclusion Criteria:
* Patients with a life expectancy of less than 3 months, planned conversion to hemodialysis, or scheduled kidney transplantation within 3 months
Study locations
- Prince of Wales Hospital. The Chinese University of Hong Kong, Hong Kong, Hong Kong
Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.
Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-09-27.